Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Amir

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 18, 2014
Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancerM G McNamara, A J Templeton, M Maganti, et al.
Journal of Medical Genetics|February 4, 2005
Mutations in exon 1 of MECP2 are a rare cause of Rett syndromeR E Amir, P Fang, Z Yu, et al.
Oncogene|April 11, 2017
Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cellsA Motzik, E Amir, T Erlich, et al.
Breast Cancer Research and Treatment|September 5, 2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancerO C Freedman, E Amir, W Hanna, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combinationM B Abou-Donia, L B Goldstein, K H Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2014
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trialsR J van Soest, A J Templeton, F E Vera-Badillo, et al.
Breast Cancer Research and Treatment|November 30, 2010
Acquisition of metastatic tissue from patients with bone metastases from breast cancerJ F Hilton, E Amir, S Hopkins, et al.
American Journal of Human Genetics|December 1, 1999
Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspotsM Wan, S S Lee, X Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2013
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trialsA J Templeton, F E Vera-Badillo, L Wang, et al.
ESMO Open|June 5, 2025
Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancerM J Elliott, J Kim, A Dou, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|March 18, 2014
Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancerM G McNamara, A J Templeton, M Maganti, et al.
Journal of Medical Genetics|February 4, 2005
Mutations in exon 1 of MECP2 are a rare cause of Rett syndromeR E Amir, P Fang, Z Yu, et al.
Oncogene|April 11, 2017
Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cellsA Motzik, E Amir, T Erlich, et al.
Breast Cancer Research and Treatment|September 5, 2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancerO C Freedman, E Amir, W Hanna, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combinationM B Abou-Donia, L B Goldstein, K H Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2014
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trialsR J van Soest, A J Templeton, F E Vera-Badillo, et al.
Breast Cancer Research and Treatment|November 30, 2010
Acquisition of metastatic tissue from patients with bone metastases from breast cancerJ F Hilton, E Amir, S Hopkins, et al.
American Journal of Human Genetics|December 1, 1999
Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspotsM Wan, S S Lee, X Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2013
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trialsA J Templeton, F E Vera-Badillo, L Wang, et al.
ESMO Open|June 5, 2025
Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancerM J Elliott, J Kim, A Dou, et al.
Pageof 9